Skip to content
Peptides Made Clear

Research area

Muscle & Recovery protocols

Muscle signaling, performance, and post-exercise recovery pathways under study.

Educational reference only. Peptides Made Clear does not provide medical advice, dosing recommendations or administration guidance. Values shown are what published sources or reviewed records report, never a suggestion for personal use.

Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
ARA-290

ARA-290 (cibinetide), an 11-amino-acid innate repair receptor agonist derived from erythropoietin helix B

Single peptideSource verified
Evidence
Early human research
Route
Subcutaneous injection in the published phase 2 human trials; intravenous in some earlier work
Schedule
Phase 2 trials used daily subcutaneous administration over defined study periods of roughly four to twenty-eight days depending on the protocol.
Vials
4 mg, 16 mg
View protocol6 citations
Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
BPC + TB
BlendSource verified
Evidence
Laboratory research
Route
Vendor listings describe subcutaneous injection of a reconstituted blend. No approved route exists for the combination.
Schedule
Not established for the combination. Any schedule shown by a seller is a marketing convention, not a studied regimen.
Vials
No verified presentation recorded
View protocol1 citation
Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
BPC-157

Pentadecapeptide BPC 157 (GEPPPGKPADDAGLV)

Single peptideSource verified
Evidence
Early human research
Route
Oral tablet and intravenous infusion in the published human studies; intraperitoneal and intragastric in the rodent literature
Schedule
Not established for any human indication. The registered human studies were dose-escalation safety designs, not schedules intended for repeated use.
Vials
5 mg, 10 mg
View protocol6 citations
Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
BPC-157 + GHK-Cu + TB-500 + KPV Blend (Klow)
BlendSource verified
Evidence
Laboratory research
Route
Vendor listings describe subcutaneous injection of a reconstituted blend. No approved route exists for the combination.
Schedule
Not established for the combination. Any schedule shown by a seller is a marketing convention, not a studied regimen.
Vials
No verified presentation recorded
View protocol1 citation
Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
IGF-1 LR3
Single peptideSource verified
Evidence
Laboratory research
Route
Sold as a lyophilised research reagent. No approved human route exists.
Schedule
Not established. No controlled human study defines a schedule.
Vials
No verified presentation recorded
View protocol1 citation
Cinematic 3D visualization of skeletal muscle fiber bundles and tendons with illuminated recovery pathways.
SS-31
Single peptideSource verified
Evidence
Early human research
Route
Subcutaneous injection in the clinical programme, with ophthalmic formulations studied separately.
Schedule
Clinical trials used daily subcutaneous administration over defined study periods.
Vials
No verified presentation recorded
View protocol1 citation